VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio access to a up to USD 75 m flexible loan facility. Homburger advised VectivBio with regard to all Swiss legal […]
Swiss FinTech startup Teylor has successfully closed its CHF 6.5 million series A2 financing round. The additional funds will be used to strengthen the market position of the Teylor lending platform, a platform providing banks, debt
Yokoy Group has completed its series B financing round raising USD 80 million in, led by US investor Sequoia Capital with participation from Speedinvest, Visionaries Club and Zinal Growth, existing investors Balderton Capital, Six FinTech Ventures,
Eppendorf, a life science company that develops, produces and distributes products and services for the use in laboratories worldwide, made an investment in BigOmics Analytics, a Swiss biodata analytics start-up company, as part of their
Niederer Kraft Frey advised Credit Suisse, acting as agent and coordinator, and further banks on a syndicated financing for Alpiq Holding. Alpiq, a Swiss energy services provider and electricity producer in Europe with a
Geberit successfully completed the placement of a CHF 150 million fixed rate bond with a term of 5.5 years and a coupon of 0.75%. Lenz & Staehelin acted as counsel to Geberit.
On March 21, 2022, UBS Group successfully completed its issuance of EUR 1.5 billion in aggregate principal amount of 1.000 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due March 2025 under its Senior Debt
Niederer Kraft Frey has advised Macquarie Group Limited (MGL) on the offering of its CHF 200 million 1.285 percent bond due September 2029. The bond is listed on SIX Swiss Exchange and represents Macquarie’s second group level
Niederer Kraft Frey advised UBS Switzerland, acting as sole coordinator, bookrunning mandated lead arranger, agent and original lender, as well as an international bank syndicate on a partially committed up to CHF 2.8 billion syndicated revolving
On March 10, 2022, Roche Holdings, Inc. successfully completed its issuance of USD 5 billion in aggregate principal amount of senior notes, consisting of USD 1.25 billion 1.882% Notes due 2024, USD 1 billion 2.132% Notes due 2025, USD 1.25 billion 2.314% Notes due 2027, USD 750 million
